Viewing Study NCT06331169


Ignite Creation Date: 2025-12-24 @ 11:02 PM
Ignite Modification Date: 2026-01-02 @ 12:56 AM
Study NCT ID: NCT06331169
Status: RECRUITING
Last Update Posted: 2024-08-30
First Post: 2024-03-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Anlotinib With Trastuzumab Deruxtecan for Previously Treated HER2-Low Advanced Breast Cancer
Sponsor: Fudan University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module